The healthcare industry has changed its focus. The needs of the patient, rather than the needs of the industry, are now at the centre of clinical studies conducted. This patient-centric approach benefits the patient and, ultimately, the success and efficiency of clinical trials.
Conducting a trial can be complicated. With patients geographically spread out, in need of frequent doses, and a drug product that has strict storage and delivery conditions, the process is even more difficult. When dealing with homebound patients, an orphan indication, or a dispersed patient population, patient enrolment and retention can be a challenge.
Specialised clinical supply managers can help a sponsor execute a directto- patient programme to overcome fundamental challenges that prevent the sponsor from conducting a trial. The programme, which provides a highly customisable solution per patient and per protocol, helps reduce the number of patient dropouts and the overall cost of a study.
|
